8legs: Simply wall st

Your Followed Topics

#1 out of 3

Takeda’s 3-month return is 0.3% with a 1-year total return of 33.8%, signaling mixed momentum despite a positive longer-term trend.
Simply Wall St places Takeda near a fair value of ¥5,590, suggesting slight overvaluation under one narrative.
A DCF analysis argues for a very different story, with a fair value of ¥14,744.38 per share.
The report cautions that equity outcomes depend on long-term cash flow assumptions and discounting.
Investors are urged to weigh risks such as Actos-related litigation and pipeline setbacks.
Takeda's portfolio includes Entyvio and Takhzyro among other brands across multiple therapeutic areas.
The article emphasizes that the analysis is general in nature and not financial advice.
The current price around ¥5,673 contrasts with the DCF-based fair value suggesting substantial upside.
Takeda’s stock momentum shows near-term strength despite longer-term questions about growth potential.
The piece highlights a list of related investment ideas including healthcare AI stocks and undervalued stocks.

Vote 0

#2 out of 3

RF Industries trades above its fair value of $10.25 as the stock market debates how much of the growth story is already priced in.
The narrative shift: from a traditional component supplier to a diversified solutions provider.
Analyst views split: a downgrade to Neutral keeps the same $10.25 target, signaling limited upside.
Key risks cited include customer concentration and tariff pressures that could impact earnings.
Fair value inputs show only minor tweaks to long-term growth and margins.
Future valuations reflect a slight discount rate adjustment, keeping overall discounting modest.
Narratives evolve as new data and commentary refresh the expected story.
The report highlights higher-value offerings like DAC cooling and small cell solutions.
No investment position is claimed by Simply Wall St in RFIL; analysis is independent.
The piece invites readers to follow the RFIL narrative for ongoing perspectives.

Vote 0

#3 out of 3100.00%

LATAM Airlines Group’s fair value target rose to 33.47 CLP from 26.74 CLP as earnings assumptions improve.
Analysts balance stronger earnings with a stock price now nearer to what models suggest is fair value.
Morgan Stanley raised its price target to $67 from $56, signaling improved earnings expectations.
New targets from Morgan Stanley and Barclays point to higher earnings forecasts amid shifting sentiment.
Goldman Sachs downgraded the stock, adding caution despite better earnings outlook.
Key growth drivers include rising air travel and cargo demand and regional partnerships.
Fleet modernization and cost discipline post-restructuring are central to efficiency and cash flow.
The report notes currency volatility and decarbonization costs as key risks.
Simply Wall St invites readers to join its Community for additional perspectives on LATAM.
The article clarifies it provides a general, data-based view and not financial advice.

Vote 0

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.